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ABSTRACT
Disruption of epithelial architecture is a fundamental event during
epithelial tumorigenesis. We show that the expression of the cancer-
promoting phosphatase PRL-3 (PTP4A3), which is overexpressed in
several epithelial cancers, in polarized epithelial MDCK and Caco2
cells leads to invasion and the formation of multiple ectopic, fully
polarized lumens in cysts. Both processes disrupt epithelial
architecture and are hallmarks of cancer. The pathological
relevance of these findings is supported by the knockdown of
endogenous PRL-3 in MCF-7 breast cancer cells grown in three-
dimensional branched structures, showing the rescue from multiple-
lumen- to single-lumen-containing branch ends. Mechanistically, it
has been previously shown that ectopic lumens can arise from
midbodies that have been mislocalized through the loss of mitotic
spindle orientation or through the loss of asymmetric abscission. Here,
we show that PRL-3 triggers ectopic lumen formation throughmidbody
mispositioning without altering the spindle orientation or asymmetric
abscission, instead, PRL-3 accelerates cytokinesis, suggesting that
this process is an alternative new mechanism for ectopic lumen
formation in MDCK cysts. The disruption of epithelial architecture by
PRL-3 revealed here is a newly recognized mechanism for PRL-3-
promoted cancer progression.
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INTRODUCTION
Defects in polarized epithelial tissue architecture are the source of
more than 80% of human cancers, and deregulation or loss of
polarity in epithelial cells is considered fundamental during tumor
progression (Datta et al., 2011; McCaffrey and Macara, 2011;
St Johnston and Ahringer, 2010). Although the phosphatase of
regenerating liver-3 (PRL-3; also known as PTP4A3) is not found in
most adult tissues, its overexpression is known to promote epithelial
tumor progression, leading to poor outcome (Guzin ́ska-
Ustymowicz and Pryczynicz, 2011; Rios et al., 2013). Moreover,
PRL-3 is an emerging prognostic marker for the prediction of
human colorectal cancer progression (Guzin ́ska-Ustymowicz and
Pryczynicz, 2011). Nevertheless, PRL-3 has not yet been
investigated in the context of epithelial architecture and polarity
(Rios et al., 2013). PRL-3 belongs to the family of the PRL proteins
within the dual specificity phosphatase (DSP) family. The PRL
family comprises three members, PRL-1, PRL-2 and PRL-3, and all
have been implicated in promoting cancer progression (Rios et al.,
2013). PRL-3 localizes to membrane compartments, mainly the
plasma membrane. Protein and non-protein substrates have been
suggested for PRL-3, but none has yet been established as a
substrate that would explain the PRL-3-dependent phenotypes
(Rios et al., 2013). PRL-3 has been shown to promote proliferation
and invasion in two-dimensional (2D) cell cultures (Al-Aidaroos
and Zeng, 2010; Rios et al., 2013).
Epithelial polarization and de novo lumen formation have been
extensively studied in 3D-cultured Madin-Darby canine kidney
(MDCK; non-cancerous), Caucasian colon adenocarcinoma (Caco-
2) and MCF-7 (Caucasian breast adenocarcinoma) cells (Apodaca,
2010; Bryant et al., 2010, 2014; do Amaral et al., 2011; Gálvez-
Santisteban et al., 2012; Jaffe et al., 2008; Lee et al., 2007;
Rodríguez-Fraticelli et al., 2015; Schlüter and Margolis, 2009). In
contact with extracellular matrix, MDCK and Caco-2 cells form
polarized spherical cysts with the apical membrane facing a single
central lumen. Similarly, MCF-7 cells form branched tubular
structures where lumens are opened in the branch ends, surrounded
by polarized cells with the apical membrane facing the lumen.
De novo lumen formation in MDCK cysts starts during the first
mitosis and requires polarized exocytosis of vesicles containing
apical markers along the mitotic spindle to the site of abscission
(Dionne et al., 2015; Li et al., 2014; Wang et al., 2014). Then, the
apical membrane initiation site (AMIS) (Apodaca et al., 2012;
Bryant et al., 2010) is formed around the midbody (Apodaca et al.,
2012; Li et al., 2014; Schlüter et al., 2009; Wang et al., 2014), a
structure created within the intercellular bridge during cytokinesis
(D’Avino and Capalbo, 2016; Overeem et al., 2015; Schlüter and
Margolis, 2009; Steigemann and Gerlich, 2009), where the apical
membrane will finally be positioned (Jaffe et al., 2008). In
subsequent cell divisions, the central single lumen is maintained
through planar orientation of the mitotic spindle during metaphase,
generating a radial cleavage furrow. This furrow ingresses
asymmetrically to locate the midbody at the apical membrane at the
end of the abscission (Bryant et al., 2010; Jaffe et al., 2008; Li et al.,
2014; Overeem et al., 2015; Schlüter et al., 2009). Loss of spindle
orientation or of asymmetric abscission results in mislocalizedReceived 31 March 2016; Accepted 16 September 2016
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midbodies, leading to ectopic lumen formation and thus disruption of
epithelial architecture (Jaffe et al., 2008; Schlüter et al., 2009).
Although loss of spindle orientation has been extensively studied
(Jaffe et al., 2008; Overeem et al., 2015), spindle orientation-
independent mislocalization of midbodies remains as a theoretical
scenario (Jaffe et al., 2008; Overeem et al., 2015; Schlüter et al.,
2009), leaving room for alternative mechanisms.
Here, we show that both the overexpression of PRL-3 in MDCK
and Caco-2 cysts and high levels of PRL-3 in MCF-7 structures
disrupt epithelial morphogenesis. PRL-3 alters the position of post-
mitotic midbodies (midbody remnants) without altering spindle
orientation or asymmetric cleavage furrow ingression, suggesting
that an alternative mechanism can occur. Our studies reveal that
PRL-3 enhances the pace of cytokinesis, leading to the hypothesis
that PRL-3 prevents the apical localization of the midbody through
early abscission, resulting in a new pathway for the disruption of
epithelial architecture. Furthermore, we show that in MDCK cysts,
the midbody is retained in the apical membrane long after cell
division, supporting a role for the midbody in polarity maintenance
in these cells besides that in de novo lumen formation, as has been
previously reported for this cell system (Jaffe et al., 2008).
RESULTS
PRL-3 overexpression affects lumen formation in epithelial
cells
Over the past few years, several reports have shown a correlation
between high pathological PRL-3 expression and tumor progression
of epithelial cancers (reviewed in Al-Aidaroos and Zeng, 2010;
Guzin ́ska-Ustymowicz and Pryczynicz, 2011; Rios et al., 2013), but
the effect of aberrant PRL-3 expression on cellular polarity has not
yet been examined. To elucidate whether PRL-3 activity induces a
cancer-relevant phenotype in polarized epithelial cells, we stably
overexpressed the wild-type (WT) version of PRL-3 fused to GFP
(GFP–PRL-3-WT) in MDCK and Caco-2 cells. As previously
reported, MDCK and Caco-2 cells form spherical cysts in Matrigel
that are characterized by a central hollow lumen surrounded by a
single layer of polarized cells (Apodaca et al., 2012; Debnath and
Brugge, 2005; Li et al., 2013). In these cysts (Fig. 1A,D; Fig. S1A,D),
actin was enriched below the apical membrane facing the central
lumen (Horikoshi et al., 2009). By contrast, PRL-3-overexpressing
cysts were frequently abnormal, with multiple lumens that were still
positive for actin (Fig. 1B,D; Fig. S1B,D). This defect depended on
PRL-3 catalytic activity becauseMDCK and Caco-2 cysts that stably
expressed the catalytically inactive mutant of PRL-3 (GFP–PRL-3-
C104S) showed a phenotype that was comparable to parent-line
(parental) cysts (Fig. 1C,D; Fig. S1C,D). To exclude that this finding
is due to different expression levels, we compared the expression
levels of PRL-3 WT and C104S in the stable cell lines (Fig. S1E).
Because PRL-3 protein levels in cells are tightly regulated (Choi
et al., 2011; Xing et al., 2016), which leads to heterogeneous PRL-3
expression in the MDCK stable cell lines (Fig. 1B,C), we used flow
cytometry to study the expression distribution of PRL-3 in these cell
lines (Fig. S1E). We observed that the proportion of MDCK
cells expressing the highest levels of GFP–PRL-3-C104S was
increased compared to the proportion of cells expressing the
highest levels of PRL-3-WT, suggesting that PRL-3 protein level
regulation might depend on PRL-3 activity. This finding also
demonstrates that the PRL-3-C104S phenotype is not due to a general
decrease of protein expression compared to that of WT.
In agreement with the single lumen phenotype observed for
PRL-3-C104S-overexpressing cysts, we observed a concentration-
dependent rescue towards the normal phenotype (Fig. 1D;
Fig. S1D) when PRL-3-WT-overexpressing cysts were treated with
the selective PRL inhibitor analog 3 (Hoeger et al., 2014). The
parental and the GFP–PRL-3-C104S MDCK stable cell lines also
showed a slightly increased number of single-lumen-containing cysts
when treatedwith analog 3 (Fig. 1D), but not the correspondingCaco-
2 cells (Fig. S1D). This could be due to the endogenous presence of
PRL proteins in MDCK cells because analog 3 inhibits all PRLs
(Hoeger et al., 2014). Endogenous dog PRL-3 protein could neither
be detected by western blot analysis in MDCK cells using different
antibodies (see Materials and Methods) nor by deep mass-
spectrometry (MS) analysis, which is used to detect low-expressing
proteins; by contrast, humanPRL-3 in the cells overexpressing human
GFP–PRL-3-WTandGFP–PRL-3-C104Swere identified. However,
peptides corresponding to endogenous PRL-1 and PRL-2 were
found, suggesting that the observed slight increase could be due to
endogenous PRL-1 and/or PRL-2. To this end, PRL-1was transiently
overexpressed in MDCK cysts. Like PRL-3, it also caused the
formation of multiple lumens, although to a lesser extent (Fig. 1E;
Fig. S1F–H), supporting the above hypothesis and indicating that
endogenous PRLs are able to exert the observed effect on lumen
formation. Nevertheless, to address whether endogenous PRL-3
could have an effect on lumen formation at low protein levels that are
undetectable by MS and antibody-mediate analyses, we knocked
down PRL-3 by using RNA interference (Fig. S1I) in MDCK and
Caco-2 cysts. No changewas observed in cyst formation compared to
that in parental cysts (Fig. 1F; Fig. S1J), supporting that PRL-3
protein is not present or expressed at very low protein levels in these
cell lines. In agreement with this, PRL-3 mRNA and protein levels
have been reported previously to not always correlate because
translational and post-translational regulation can tightly control
protein levels (Choi et al., 2011;Wang et al., 2010; Xing et al., 2016).
Given that PRL-3 protein was not detected in MDCK and Caco-2
cells, it was not possible to study a potential endogenous role of
PRL-3 using these cell systems. Thus, we used MCF-7 breast cancer
cells, the only cell line where detectable levels of PRL-3 protein have
been reported (Geiger et al., 2012; Wang et al., 2010) and that can be
cultured to grow in three dimensions and to form lumen-containing
structures (doAmaral et al., 2011; Lee et al., 2007). In the branch ends
of these structures, single or multiple lumens opened, and these
lumens were positive for actin (Fig. 1G). When the cells were treated
with the PRL inhibitor analog 3, the proportion of single-lumen-
containing branch ends increased in a concentration-dependent
manner (Fig. 1G). This was also the case when PRL-3 was stably
knocked down (Fig. 1H; Fig. S1K). This result corroborates the
phenotype observed with PRL-3 overexpression and suggests a
pathophysiological role of PRL-3 in disrupting epithelial architecture.
PRL-3-mediated cell proliferation and invasion, also hallmarks
of cancer cells, have never been studied in polarized cells. To test for
an invasive phenotype, MDCK parental and GFP–PRL-3-
overexpressing cysts were grown in Matrigel–collagen-I (1:1)
(Kwon et al., 2011). The MDCK GFP–PRL-3-WT cysts showed
a tubular invasive phenotype compared to that of parental and GFP–
PRL-3-C104S MDCK cysts (Fig. S1L–O). Regarding proliferation,
the size of MDCK GFP–PRL-3-WT cysts, measured at 72 h,
showed no difference in comparison to the size of parental and
GFP–PRL-3-C104S MDCK cysts (Fig. S1P), suggesting that PRL-
3 does not induce proliferation in this system up to this stage.
Interestingly, GFP–PRL-3-C104S MDCK cysts developed smaller
lumens than the parental cysts, caused by an increased length of
the apical–basal axis of the cells (Fig. 1I), which could be an
intermediate phenotype between the normal phenotype of MDCK
cysts and the multi-lumen phenotype of MDCK GFP–PRL-3-WT
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cysts. This could be induced by a substrate-trapping effect, as GFP–
PRL-3-C104S can potentially still bind to but not process its
substrates.
Taken together, these results show that aberrant PRL-3 expression,
mimicking the pathological expression in epithelial cancers, has a
detrimental effect on epithelial architecture and increases cell
invasion. Because high levels of PRL-3 also induce multiple
lumens in MCF-7 breast cancer 3D cell structures, low abundance
or absence of PRL-3 might be needed in healthy epithelial cells to
ensure correct tissue formation. In the following, we focused on
studying the disruption of epithelial architecture in MDCK cysts
caused by PRL-3 activity, as this is a newly discovered phenotype.
PRL-3-induced fully polarized ectopic lumensarise fromPRL-
3-enriched incorrectly localized AMISs
MDCK cells establish apical–basal polarity at a very early stage of
cystogenesis, when the membranes that face the center of the cyst
acquire a clear apical identity and well-defined tight junctions are
formed right after the first cell division (Apodaca, 2010; Apodaca
et al., 2012; Bryant et al., 2010). To further characterize PRL-3-
induced ectopic lumens, we investigated the localization of tight
junctions in PRL-3-WT cysts. The tight junction marker ZO-1 (also
known as TJP1) localized to the apical sites of cell–cell contact that
were adjacent to the central lumen in parental and GFP–PRL-3-
C104S MDCK cysts (Fig. 2A,B,D; Fig. S2A,B), as previously
Fig. 1. PRL-3 expression in epithelial cells leads to the formation of aberrant multiple-lumen-containing cysts. (A–C) 3D reconstruction of parental
(A) MDCK cysts and of MDCK cysts overexpressing GFP–PRL-3-WT (B) or GFP–PRL-3-C104S (C) (green) at 72 h. Scale bars: 10 μm. Representative 2D plane
from the selected cysts is shown in the bottom-left corner. Blue, nuclei; red, actin. Scale bars: 5 µm. (D) Percentage of cysts with a single lumen in 72-h MDCK
cysts or cysts that stably expressed GFP–PRL-3-WT or GFP–PRL-3-C104S. Cells were treated with analog 3 or DMSO (control, 0 µM analog 3). n=300.
(E) Percentage of cysts with a single lumen in 72-h MDCK cysts that transiently expressed GFP–PRL-1-WT or GFP–PRL-3-WT. n=300. (F) Proportion of 48-h
single-lumen MDCK cysts that had been electroporated with control siRNA or siRNA against PRL-3. PRL-3 mRNAwas assayed by performing one-step RT-PCR
using mRNA encoding β-actin as a loading control, n=300. (G,H) 3D reconstruction of an MCF-7 branched tubular structure after 15 days of growth. Dashed
square highlights a branch end that presents a single lumen (middle panel, top) or multiple lumens (middle panel, bottom). Graph represents the proportion of
branch ends that exhibited a single lumen. Cells were treated with analog 3 or DMSO (control, 0 µM analog 3) (G) or with 1 mM IPTG for MCF-7 cells that stably
expressed IPTG-inducible control shRNA or shRNA against PRL-3 (H). n=300. Scale bars: 100 µm (left), 50 µm (middle column). (I) Lumen radius, and distance
between apical and basal membranes measured in parental and GFP–PRL-3-C104S MDCK cysts. n=90. Values in D–I represent mean±s.d. of three biological
replicates. **P≤0.01, ***P≤0.001 and ****P≤0.0001 (D,I, ordinary two-tailed two-way ANOVA with Tukey's multiple comparison test; E,G,H, ordinary two-tailed
one-way ANOVA with Tukey's multiple comparison test; F, t-test compared to control siRNA).
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Fig. 2. See next page for legend.
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reported for the parental cysts (Bryant et al., 2010; Martin-Belmonte
et al., 2007). PRL-3-induced ectopic lumens were still flanked by
tight junctions (Fig. 2C–E; Fig. S2C). 3D analysis of 660 cysts
showed that these ectopic lumens are shared by two or more cells,
thus they seem to arise between lateral membranes (Movie 1). They
can be symmetric between both cells or invasive towards one of the
cells (Fig. 2C,E; Fig. S2C, Movie 1). In agreement with the intact
tight junctions observed in the PRL-3-overexpressing cysts, de novo
tight junction formation was undisturbed by PRL-3 in a de novo
tight junction formation assay (Fig. S2D).
Two of the suggested PRL-3 substrates, phosphatidylinositol 4,5
bisphosphate [PI(4,5)P2] (McParland et al., 2011) and ezrin (Forte
et al., 2008), are particularly interesting with respect to their
potential involvement in the mechanism by which PRL-3 could
cause this phenotype because they are known determinants of
cellular polarity (Martin-Belmonte et al., 2007), marking the apical
membrane. In MDCK parental and PRL-3-overexpressing cysts,
ezrin was present in the apical membrane and partially colocalized
with overexpressed GFP–PRL-3-WT and GFP–PRL-3-C104S
(Fig. 2F–I; Fig. S2E). Compared to ezrin, phosphorylated ezrin
colocalized to a lesser extent with both PRL-3-WT and with PRL-3-
C104S (Fig. 2I), suggesting that this difference was not due to
dephosphorylation. Consistent with this, there was no difference in
the ratio between the fluorescence intensity of phosphorylated ezrin
and ezrin in parental, GFP–PRL-3-WT- and GFP-PRL-3-C104S-
expressing cysts (Fig. 2J). Similarly, PI(4,5)P2 was present at the
apical membrane in parental and mKate–PRL-3-overexpressing cysts
and colocalized with mKate–PRL-3 (Fig. S2F–H). However, no
obvious differences in the fluorescence intensity of the PI(4,5)P2
sensor GFP–PH-PLCδ at the apical membrane was detected
(Fig. 2K). The overall phosphatidylinositol bisphosphate (PIP2)
content in MDCK cysts was also measured by performing
quantitative MS, with which one cannot distinguish between the
three PIP2 species. In comparison with controls, no difference was
detected when GFP–PRL-3-WT was overexpressed (Fig. 2L; Fig.
S2I). Interestingly, however, when overexpressing the phosphatase
PRL-1, which cannot dephosphorylate PI(4,5)P2 (Rios et al., 2013;
Sun et al., 2007), we observed a similar but weaker phenotype
compared to that upon PRL-3 overexpression (Fig. 1E), with similar
expression levels of PRL-1 and PRL-3 (Fig. S1F–H). This difference
could thus be due to the different activities toward PI(4,5)P2, but other
effects cannot be excluded.
Because the ectopic lumens appeared to be fully specified, and
tight junction formation was undisturbed, we hypothesized that
PRL-3 catalytic activity might rather lead to a failure in lumen
positioning. AMIS specification is one of the earliest steps in
lumenogenesis and precedes the formation of a tight-junction-
delimited lumen (Apodaca, 2010; Bryant et al., 2010). As expected,
in parental and PRL-3-C104S MDCK cysts, the AMIS marker Sec8
was present at cell–cell contacts at the center of the cysts – the site
at which the lumen opened (Fig. 2M,N,P). In PRL-3-WT-
overexpressing cysts, Sec8 localized to PRL-3 patches, suggesting
that the AMIS is properly formed before lumen opening (Fig. S2J).
However, the AMIS was mislocalized from the center of the cyst to
the lateral membrane (Fig. 2O,P).
Taken together, these results indicate that PRL-3 catalytic activity
leads to a failure in the specification of the lumen position rather
than to a disruption in overall cell polarity, giving rise to fully
polarized lumens in ectopic positions. Therefore, PRL-3 appears to
interfere at an early step in lumenogenesis.
PRL-3 affects lumen positioning by altering the post-mitotic
midbody localization
It has been described previously that the AMIS is formed around the
midbody at the site of and during cytokinesis (Li et al., 2014). It has,
furthermore, been reported that the midbody positions the apical
membrane during and right after cytokinesis (Jaffe et al., 2008;
Overeem et al., 2015; Schlüter et al., 2009), but its fate afterwards
remains unstudied in MDCK and Caco-2 cysts. Nevertheless, it has
been stated that post-mitotic midbodies can participate in functions
unrelated to cytokinesis in other cell types (Chen et al., 2013; Kuo
et al., 2011; Morais-de-Sá and Sunkel, 2013; Pollarolo et al., 2011).
In order to examine the positions of midbodies in PRL-3-
overexpressing MDCK cysts, we examined different midbody
markers. When the lumen had not yet opened, the midbody markers
MKLP1 (KIF23), Cep55, Aurora kinase B and γ-tubulin marked the
central lumen in parental and GFP–PRL-3-C104S MDCK cysts
(Fig. 3A,B,D; Fig. S3A,B,E,F), and these proteins were also
identified in the ectopic lumens formed in GFP-PRL-3-WTMDCK
cysts (Fig. 3C,D; Fig. S3C,G,H). Because Cep55 can be also found
in other subcellular structures – e.g. in the centrosome (Martinez-
Garay et al., 2006) – and because the antibody against MKLP-1
generates background in immunofluorescence analyses, the
colocalization between Cep55 and MKLP1 was quantified in
punctate structures in the lumens to ensure that the luminal
structures were midbodies (Fig. S3D). Moreover, in MDCK and
Caco-2 cysts that overexpressed GFP–PRL-3-WT, ∼30–50% of
midbody remnants were incorrectly localized in the lateral
membrane compared to the central (apical) localization in parental
and GFP–PRL-3-C104S MDCK cysts at early cystogenesis stages
(Fig. 3E; Fig. S3I). To follow the position of post-mitotic midbodies
over time in morphologically normal PRL-3-C104S and also PRL-
3-WT cysts, we next performed live-cell imaging experiments using
YFP–MKLP1 as a midbody remnant marker. At the two-cell stage,
Fig. 2. PRL-3-overexpressing cysts show fully specified ectopic lumens
that arise from PRL-3-enriched incorrectly localized AMISs.
(A–D) Localization of ZO-1 (magenta) in a 72-h MDCK cyst (A) and cysts
expressing GFP–PRL-3-C104S (B) or GFP–PRL-3-WT (C) (both proteins in
green). Blue, nuclei; red, actin. Right: separated fluorescence channels of the
indicated regions showing the indicated staining. Scale bars: 10 µm. (D) The
proportion of cysts with ZO-1 staining in the nascent lumen. n=90. See also
Movie 1. (E) Schematic representation of MDCK cells overexpressing PRL-3-
WT showing an asymmetric invasive ectopic lumen flanked with ZO-1 (magenta
dots). (F–H) Experiments as described in A–C, except cysts were stained with
antibodies against ezrin (red) and threonine-phosphorylated ERM (ezrin-radixin-
moesin) proteins (pERM) (magenta). Right: separate fluorescent channels
showing the indicated staining. Scale bars: 10 µm. (I) Global Pearson correlation
wasmeasured to study colocalization between PRL-3-WTor PRL-3-C104S and
ezrin or pERM. n=90. (J) Ezrin dephosphorylation was determined by
calculating the fluorescence intensity ratio between pERM and ezrin in parental,
GFP–PRL-3-WT and GFP–PRL-3-C104S MDCK cysts. n=90. (K) PI(4,5)P2
dephosphorylation in apical membranes was determined by calculating the ratio
between apical and the combined cytosolic and basal fluorescence intensity of
GFP–PH-PLCδ in parental, GFP–PRL-3-WT and GFP–PRL-3-C104S MDCK
cysts. n=90. (L) Quantitative lipidMS analysis of MDCK cysts or cysts that stably
expressed GFP–PRL-3-WT or GFP–PRL-3-C104S analyzed 5 days after
seeding. The ratio between the total phosphatidylinositol phosphates PIP and
PIP2 was quantified. (M–P) Localization of Sec8 (magenta) in 48-h MDCK cysts
with nascent lumen. Parental cysts (M) and cysts that stably expressed PRL-3-
C104S (N) or PRL-3-WT (O) are shown. Blue, nuclei; red, actin. Bottom:
focus on the indicated regions showing individual channels of the indicated
GFP–PRL-3 construct or actin (left), Sec8 (middle) and the merged image
(right). (P) The proportion of cysts with central Sec8 staining. n=90. Scale bars:
10 µm. Values in D,I,K,L,P represent the mean±s.d. of three biological
replicates. ns, not significant; ****P≤0.0001 (D,J,K,L,P, ordinary two-tailed one-
way ANOVA with Tukey’s multiple comparison test; I, ordinary two-tailed two-
way ANOVA with Tukey's multiple comparison test).
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Fig. 3. PRL-3 activity alters the position of the post-mitotic midbody. (A–D) 3D reconstruction images of 48-h parent cysts (A), of MDCK cysts overexpressing
GFP–PRL-3-C104S (B) or GFP–PRL-3-WT (C) (both in red) and stained for MKLP1 (green) to visualize midbody remnants. Nuclei, blue; actin, red in A. Bottom:
individual channels (left, middle) and merged images (right) of the indicated regions. Arrows indicate midbody remnants. (D) The proportion of cysts presenting
midbodies in the nascent lumen. n=90. Scale bars: 10 µm. (E) Midbody remnants (MKLP1, red) in 48-h cysts expressing GFP–PRL-3 WT (green). Arrows indicate
midbody remnants with central (apical, left) or lateral (right) localization. The proportion of midbody remnants showing central (apical) or lateral localization in MDCK
cysts and cysts that stably expressed GFP–PRL-3-WT and GFP–PRL-3-C104S were analyzed at 48 h after seeding. n=90. (F,G) Selected time points during live-cell
imaging of 45-h cysts that transiently co-expressed either mKATE-PRL-3-C104S (H) or mKATE-PRL-3-WT (I) and YFP–MKLP1. The arrow in F highlights the
firstmidbody remnant; arrowhead highlights themidbody remnant coming from the second cytokinesis event. Arrow inG indicates amidbody remnant that gets retained
at the lateral plasma membrane with subsequent ectopic lumen formation. Representative results of three biological replicates are shown. See also Movies 2 and 3.
Scale bars: 10 µm. (H–K) Experiments were performed as described in A–D, except cysts were analyzed at 72 h after seeding. Arrows indicate midbody
remnants. Bottom: individual channels (left, middle) andmerged images (right) of the indicated regions. Data aremean±s.d. n=90. ***P≤0.001 (D,K, ordinary two-tailed
one-way ANOVAwith Tukey’s multiple comparison test; E, ordinary two-tailed two-way ANOVAwith Tukey’s multiple comparison test). Scale bars: 10 µm.
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PRL-3-C104S cysts maintained the post-mitotic midbody at their
center (Fig. 3F, arrow; see also Movie 2). In contrast, PRL-3-WT
overexpression altered the post-mitotic midbody position from the
apical to the lateral membrane, with subsequent formation of PRL-
3-rich patches, previously identified as AMISs, around the midbody
at that position (Fig. 3G, arrow; see also Movie 3). These results
corroborate our observation that the ectopic lumens arise at the
lateral membrane (Fig. 2E).
Interestingly, in Fig. 3F, the first midbody (arrow) was
maintained over time at the edge of the lumen after subsequent
divisions. Therefore, we examined midbody markers at a later
cystogenesis stage in MDCK cysts. We observed that midbody
remnants persisted after lumen opening, delineating the edge of
the central and also ectopic lumens in parental and PRL-3-
overexpressing cysts (Fig. 3H–K; Fig. S3J–M, see also Movie 4),
similar to previous observations in proliferative zones of epithelial
surfaces in mice (Maliga et al., 2013). This could suggest that in
addition to positioning the apical membrane, midbodies could have
a role in lumen and cell polarity maintenance given that they persist
at the edge of the lumen instead of being internalized or degraded.
Taken together, these results show that PRL-3 activity leads to
lateral mispositioning of the midbody, resulting in ectopic lumen
formation.
PRL-3 alters the post-mitotic midbody position by
accelerating cytokinesis timing
Planar orientation of the mitotic spindle during metaphase and
asymmetric cell division is required to localize the midbody at the
apical membrane (Bryant et al., 2010; Jaffe et al., 2008; Li et al.,
2014; Overeem et al., 2015; Schlüter et al., 2009). Mitotic spindle
misorientation has been extensively studied because it is implicated
in epithelial tumorigenesis (Noatynska et al., 2012; Pease and
Tirnauer, 2011). Indeed, knockdown of proteins like Par3 or Cdc42
impairs spindle orientation, showing a similar phenotype (Hao
et al., 2010; Jaffe et al., 2008) to that which we observe with PRL-3
overexpression. Thus, we determined whether aberrant expression
of GFP–PRL-3-WT leads to the misorientation of the mitotic
spindle. In GFP–PRL-3-WT-overexpressing MDCK cysts, mitotic
spindles that were measured at metaphase as previously described
(Hao et al., 2010; Jaffe et al., 2008; Rodriguez-Fraticelli et al., 2010;
Wei et al., 2012; Zheng et al., 2010) were predominantly
perpendicular to the apical–basal axis (Fig. 4A), suggesting that
PRL-3 might lead to the failure of the apical delivery of the midbody
by altering the asymmetric abscission, a process that so far has been
a theoretical scenario (Jaffe et al., 2008; Overeem et al., 2015).
Accordingly, furrow ingression was measured in MDCK cysts, as
previously described (Liu et al., 2012), but GFP–PRL-3-WT did not
result in a shift of asymmetric abscission when overexpressed,
compared to parental and GFP–PRL-3-C104S-overexpressing
MDCK cysts (Fig. 4B). Thus, PRL-3 must alter midbody
positioning through an unknown alternative mechanism.
We noted that during cytokinesis, PRL-3-WT and PRL-3-C104S
were always (n=30) recruited to the cytokinetic bridge (Fig. 4C,D;
see also Movie 5). Therefore, we studied whether PRL-3
overexpression affects the cytokinesis process. An effect of
PRL-3 in cytokinesis has never been addressed previously. At
early cytokinetic stages, Aurora kinase B is activated by
phosphorylation. It in turn phosphorylates MKLP1, preventing
cleavage furrow regression (Steigemann et al., 2009). ZM447439,
an Aurora kinase B inhibitor, prevents MKLP1 phosphorylation,
leading to tetraploidization as a result of furrow regression (Ikezoe
et al., 2007; Steigemann et al., 2009). Accordingly, in order to study
whether PRL-3 prevents abscission, the tetraploid MDCK cell
population (2D culture) was measured by performing flow
cytometry analysis. As expected, the tetraploid cell population
increased in ZM447439-treated compared to the non-treated
MDCK cells (Fig. 4E,F). When GFP–PRL-3 WT was
overexpressed, the population of tetraploid cells was comparable
to that in non-treated parental and GFP–PRL-3-C104SMDCK cells
(Fig. 4E–H). Thus, we did not observe prevention of abscission by
PRL-3. We then measured the abscission time in 2D-cultured
parental MDCK cells, as well as in GFP–PRL-3-WT- and GFP–
PRL-3-C104S-overexpressing cells. Fig. 4I shows that abscission
was faster when PRL-3-WT was overexpressed (see also Movies 6
and 7). This could in turn result in a new scenario in which
abscission takes place earlier than the apical positioning of the
midbody, leading to lateral ectopic lumen formation.
DISCUSSION
PRL-3 protein is either not expressed or expressed at low levels in
healthy human epithelial tissue (Matter et al., 2001; Rios et al.,
2013). Furthermore, in MDCK and Caco-2 epithelial cell lines,
which have been extensively used for cell polarity studies, PRL-3
was undetectable at the protein level, and knockdown did not show
any effect, showing that PRL-3 is not required for the establishment
of cell polarity. However, PRL-3 is found overexpressed in many
epithelial cancers (Al-Aidaroos and Zeng, 2010; Rios et al., 2013).
Here, we found that the breast cancer cell line MCF-7 that expresses
detectable levels of PRL-3 protein (Geiger et al., 2012; Wang et al.,
2010) showsmultiple-lumen-containing branch ends when grown in
Matrigel. This phenotype can be rescued by inducible knockdown of
PRL-3 and with the PRL inhibitor analog 3, suggesting that aberrant
PRL-3 expression disrupts the epithelial architecture. In addition, the
strong phenotype when overexpressing PRL-3 in the non-cancerous
MDCK cysts suggests that PRL-3 expression in healthy epithelial
tissue is detrimental and has to be avoided, explaining its absence in
healthy epithelial tissue.Whether PRL-3 is a bona fide oncogene has
not yet been addressed in detail, although a report using PRL-3-
knockout mice shows that the absence of the PRL-3 gene leads to a
50% decrease of tumor formation in a colon cancer model
(Zimmerman et al., 2013). Our data support these findings given
that the overexpression of PRL-3 in the non-cancerous background
(MDCK cysts) causes invasiveness and detrimental disorganization
of epithelial structures, which are both fundamental events in tumor
progression (McCaffrey and Macara, 2011).
In order to answer how PRL-3 activity causes the disruption of
epithelial architecture, knowledge of its cellular substrates is required.
The identification of PRL-3 substrates has remained extremely
challenging since its discovery over a decade ago (Al-Aidaroos and
Zeng, 2010; Rios et al., 2013). In the context of lumen formation,
the suggested PRL-3 substrates PI(4,5)P2 and ezrin are known
determinants of cellular polarity (Martin-Belmonte et al., 2007).
Nevertheless, we did not observe substantial changes in the
phosphorylation status of PI(4,5)P2 and ezrin when overexpressing
PRL-3. Rapid changes in tightly controlled phosphorylation levels, as
during cleavage furrow ingression during asymmetric abscission,
could, however, be difficult to detect, and it will take the development
of elaborate and sensitive methods to make progress in this area.
During cell division of polarized cells, endosomes containing
apical components move along central spindle microtubules to fuse
with the cleavage furrow plasma membrane around the midbody,
which would finally generate an apical lumen (Li et al., 2014). In
further cell divisions, positioning of the midbody in the apical
membrane is required for correct lumenogenesis and has been
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Fig. 4. PRL-3 accelerates cytokinesis. (A) Representative images of metaphase cells in 72-h parental MDCK cysts or cysts that stably expressed GFP–PRL-3-
WT or GFP–PRL-3-C104S (green). Blue, nuclei; red, γ-tubulin. Arrows indicate the orientation of the mitotic spindles. The spindle angle was analyzed. deg,
degree. MDCK and PRL-3-C104S, n=21; PRL-3-WT, n=22. Scale bars: 10 µm. (B) Representative images of cells undergoing cytokinesis in 72-h parental MDCK
cysts or cysts that stably expressed GFP–PRL-3-WT or GFP–PRL-3-C104S (green). Blue, nuclei; red, actin; magenta, anillin (cleavage furrow). Dashed boxes
highlight the cell undergoing abscission. Merged and split channels of the selected region are shown below the picture. Asymmetry was measured when the
cleavage furrow was around 50% ingressed (measured as distance between apical and basal membrane). A line tangent to the apical membrane and
another tangent to the basal membranewere drawn. The distance between each line and the cleavage furrow was measured to determine the ingression for both
the basal and the apical side, and the ratio between the basal and apical membrane ingression was plotted. Symmetric abscission=1. n=45. Scale bars: 10 µm.
(C,D) 48-h MDCK cysts overexpressing GFP–PRL-3-WT (C) or GFP–PRL-3-C104S (D). Arrows indicate PRL-3 accumulation in the ingressed furrow. n=30.
See also Movie 5. Scale bars: 10 µm. (E–H) Cell cycle analysis. MDCK cells (E), MDCK cells treated with 2 μMof ZM447439 (Aurora kinase B inhibitor) over 48 h
(F) andMDCK cells that stably expressed GFP–PRL-3-WT (G) or GFP–PRL-3-C104S (H) were analyzed by performing flow cytometry. Blue, G0 and/or G1; olive
green, S phase; green, G2; white, tetraploid cell. (I) The time taken for cells to undergo abscission was measured in MDCK cysts and MDCK cysts
expressing GFP–PRL-3-WT or GFP–PRL-3-C104S that had also been transfected with Aurora kinase B to track cytokinesis over time. See also Movies 6 and 7.
n=50. Median (A) or mean (B,I) values for each condition from three biological replicates is shown as a line. ns, not significant; ***P≤0.001; ****P≤0.0001 (A,B,I,
ordinary two-tailed one-way ANOVA with Tukey's multiple comparison test).
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proposed to be achieved through the combination of planar mitotic
spindle orientation and asymmetric cleavage furrow ingression
(Fig. 5A) (Bryant et al., 2010; Jaffe et al., 2008; Morais-de-Sá and
Sunkel, 2013). Polarity proteins such as Par3 and Cdc42 have been
reported to be important for establishment of correct spindle
orientation (Fig. 5B), whereas spindle-independent midbody
mispositioning remains a theoretical model (Fig. 5C) (Dionne
et al., 2015; Hao et al., 2010; Jaffe et al., 2008). However, PRL-3
overexpression disrupted neither spindle orientation nor asymmetric
cleavage furrow ingression, suggesting that a third alternative
mechanism for midbody mispositioning might exist. Cytokinesis
plays a key role in midbody apical positioning (Li et al., 2014;
Overeem et al., 2015; Wang et al., 2014). Here, we show that PRL-3
localizes to the cytokinetic bridge and accelerates abscission timing.
Based on these findings, we propose that prevention of the apical
positioning of the midbody and completion of abscission in the
lateral membrane could be caused by faster cytokinesis (Fig. 5D).
The molecular mechanisms underlying the timing of asymmetric
abscission in epithelial cells are thought to be complex and include an
abscission checkpoint that is still not well understood (Caballe et al.,
2015; Lafaurie-Janvore et al., 2013).We did not observe a defect in the
ploidy of the cells, which makes a disruption of the furrow regression
rather unlikely. One possible scenario is that PRL-3 could be acting
downstream of Aurora kinase B, causing a failure in abscission delay –
for example, by counteracting Unc-51-like kinase 3, which is needed
for the final stages of abscission (Caballe et al., 2015). In general, the
knowledge of the roles and involvement of particular phosphatases in
cytokinesis is very limited (Caballe et al., 2015). However, although
PRL-3 localizes to the site of cytokinesis, it is unclear if its
involvement is direct or indirect given that PRL-3 expression in cells
affects a plethora of pathways (Rios et al., 2013). This new direction in
PRL-3 research will be addressed in future studies.
For the first time, we provide experimental evidence for an
alternative model for the disruption of cystogenesis by ruling out the
previously reported models and showing that the overexpression of
the cancer-promoting phosphatase PRL-3 leads to faster abscission.
Moreover, it has been suggested previously that midbody remnants
can participate in non-cytokinetic functions, such as cell fate
determination and cell polarity specification (Chen et al., 2013;
Crowell et al., 2014; Kuo et al., 2011; Morais-de-Sá and Sunkel,
2013). In line with this, our results confirm that midbodies have
essential functions in de novo lumenogenesis and lumen growth
during cytokinesis, and right after abscission (Jaffe et al., 2008; Li
et al., 2014; Schlüter et al., 2009), and suggest that they play a role
long after cell division in polarity maintenance or specification
given that, instead of being degraded, the midbody remnants
delineate the apical membrane.
In conclusion, we identify the first enzyme, PRL-3, that is
involved in epithelial architecture disruption through midbody
mislocalization that does so without perturbing the mitotic spindle
orientation or asymmetric cleavage furrow ingression. Instead, we
suggest a new alternative scenario in which abscission takes place
before the midbody can reach the apical position, leading to lateral
retention of the midbody. Disruption of epithelial architecture by
PRL-3 is a newly recognized mechanism through which PRL-3 can
contribute to cancer progression.
Fig. 5. Mechanisms for ectopic lumen formation through post-mitotic midbody mispositioning. During normal cystogenesis, the mitotic spindle is
positioned perpendicular to the apical–basal axis, followed by asymmetric furrow ingression for apical delivery of the midbody to ensure maintenance of a single
lumen (A). Loss of mitotic spindle orientation (B) or loss of asymmetric furrow ingression (C) can lead to failure in apical midbody positioning and an ectopic lumen
is formed. Moreover, we propose a new mechanism in which cytokinesis occurs earlier, and abscission takes place before the midbody reaches its luminal
position (D). Midbodies (MBs) from previous cell divisions remain at the apical surface. Apical membrane, red; γ-tubulin, dark red; nuclei and chromosomes,
blue; midbody and midbody remnants, green. Adapted from Jaffe et al. (2008). This figure is published under a Creative Commons BY-NC-SA license
(https://creativecommons.org/licenses/by-nc-sa/3.0/).
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MATERIALS AND METHODS
Cell culture
MDCK cells were grown in minimum essential medium (MEM) containing
10% fetal bovine serum (FBS) (both fromGibco, Life Technologies), 100 U/
ml penicillin and 100 μg/ml streptomycin (Sigma) and 2 mM L-glutamine
(Sigma). The Caco-2 cell line was cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 4.5 g/l glucose, 10%FBS, 100 U/ml penicillin
and 100 μg/ml streptomycin, 2 mML-glutamine and 0.01 mg/ml transferrin
(BD Bioscience). The MCF-7 cell line was cultured in DMEM containing
4.5 g/l glucose, 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin
and 2 mM L-glutamine. MDCK cells were provided by Fernando Martín-
Belmonte [Centro de Biología Molecular Severo Ochoa, Consejo Superior
de Investigaciones Científicas (CSIC), Madrid, Spain] and Caco-2 and
MCF-7 cells were available at EMBL Heidelberg. MDCK and Caco-2 cells
that stably expressed GFP–PRL-3 (either WT or C104S) were generated
through transfection (with Lipofectamine LTX, Life Technologies) of
pEGFP-C1-PRL-3-WT or pEGFP-C1-PRL-3-C104S accordingly. MDCK
cells that stably co-expressed GFP–PH-PLCδ andmKate–PRL-3 (eitherWT
or C104S) were generated through transfection of pEGFP-PH-PLCδ with
pmKATE2-C-PRL-3 (WTorC104S) accordingly, and double selectionwith
4 mg/ml of Geneticin and 5 μg/ml of Blasticidin S (Invitrogen) for 2 weeks.
In all cases, resistant clones were selected with 4 mg/ml of Geneticin (Gibco,
Life Technologies) for 2 weeks, and a pool of GFP-positive cells was
isolated by using fluorescence-activated cell sorting. All cell lines were
regularly authenticated by examining the formation of the characteristic
morphology in 3D culture and were tested for mycoplasma contamination
(Lonza MycoAlert; catalog no. LT07-118).
Cyst Matrigel culture
Cell cyst formationwas performed as described previously (Martin-Belmonte
et al., 2007). Briefly, MDCK, Caco-2 or MCF-7 cells were trypsinized to a
single cell suspension of 5×104 cells/ml in complete medium containing 2%
for MDCK, 5% for Caco-2 or 10% for MCF-7 of Matrigel (BD Bioscience).
Suspensions (250 μl) were plated onto 8-well coverglass chambers (Nunc),
pre-coated with 10% Matrigel in MEM serum-free for MDCK and Caco-2
cells, or with 100% Matrigel for MCF-7 cells. In order to inhibit PRL-3,
analog 3 (Enamine) was added to MDCK, Caco-2 and MCF-7 cysts.
Plasmids and PRL-3 knockdown
Vectors pEGFP-C1 and pmKATE2-C were used to overexpress WT human
PRL-3. The PRL-3-C104S mutant was generated by using site-directed
mutagenesis (McParland et al., 2011). YFP–MKLP1 was a gift from
Dr Rainer Pepperkok (EMBL, Heidelberg, Germany). For transient
pmKATE2-C-PRL-3-WT and YFP–MKLP1 expression, MDCK cells in
2D culture were transfected (Lipofectamine LTX, Life Technologies) before
plating for 3D culture. For transient pEGFP-PRL-1-WT and pEGFP-PRL-3-
WT expression, MDCK cells in 2D were transfected by electroporation
using Amaxa SF Cell Line 4D-Nucleofector kit in a 4D-Nucleofector Core
Unit instrument and the transfection program CA-152 (Lonza) before
plating for 3D culture. Synthetic double-stranded small interfering (si)RNA
was commercially obtained from Ambion (Life Technologies): Silencer
Select Negative Control #1 siRNA and PRL-3 siRNA (sense 5′-
CCUUCAUUGAGGACCUGAATT-3′). Both siRNAs were used at
10 nM. In MDCK cells, siRNAs were transfected by electroporating cells
using the Amaxa SF Cell Line 4D-Nucleofector kit in a 4D-Nucleofector
Core Unit instrument and the transfection program CA-152 (Lonza). In
Caco-2 cells, siRNAs were transfected with jetPRIME (Polyplus
transfection). The PRL-3 mRNA level was determined by performing
one-step reverse transcription (RT)-PCR (Qiagen). For inducible PRL-3
knockdown in MCF-7 cells, stable expression of small hairpin (sh)RNA
against PRL-3 was established. MISSION 3X LacO Inducible Non-Target
shRNA Control plasmid DNA (Sigma, catalog no. SHC332) was used as a
control shRNA and, for PRL-3 knockdown shRNA, sense sequence 5′-
CCGGAGCTCACCTACCTGGAGAAATCTCGAGATTTCTCCAGGT-
AGGTGAGCTTTTTTG-3′, extracted from MISSION shRNA plasmid
DNA, was inserted into the isopropyl β-D-1-thiogalactopyranoside (IPTG)-
inducible vector pLKO-puro-IPTG-3×LacO. MCF-7 cells were transfected
(Lipofectamine LTX, Life Technologies) with both constructs, resistant
clones were selected with 1 μg/ml of puromycin dihydrochloride (Santa
Cruz Biotechnology), and single clones were expanded and selected by
performing OneStep RT-PCR analysis (Qiagen) after 4 days of induction
with 1 mM IPTG (Peqlab). IPTG-containing medium was replaced with
fresh every 2 days.
Antibodies and immunolabeling
Primary mouse antibodies used were: anti-Sec8 (1:100; Enzo Life Sciences;
catalog no. ADI-VAM-SV016; clone 14G1; lot 08010910), which also
nonspecifically stained nuclear structures; anti-Aurora-kinase-B (1:200; BD
Transduction Laboratories; catalog no. 611082; clone 6/AIM-1); anti-γ-
tubulin (1:100; Sigma; clone GTU-88) and anti-ezrin (1:100; BD
Transduction Bioscience; catalog no. 610602; lot 87352) antibodies.
Primary rabbit antibodies used were: anti-MKLP1 (1:1000; Santa Cruz
Biotechnology; catalog no. sc-867; clone N-19; lot I1614); anti-α-tubulin
(1:500; Millipore; catalog no. 04-1117; clone EP1332Y) and anti-ZO-1
(1:200; Invitrogen; catalog no. 40-2200; clone TJP1) antibodies. An anti-
phosphorylated-ERM antibody, which detects phosphorylation of ezrin (at
Thr-567), radixin (at Thr-564) and moesin (at Thr-558) (1:100; Abcam;
catalog no. ab76247; clone EP2122Y; lot GR14705-13), was used in the
experiments to detect phosphorylated ezrin given that MDCK cells express
mainly ezrin in terms of ERM-family proteins (Wakayama et al., 2011).
Primary goat antibodies used were against Cep55 (1:100; Santa Cruz
Biotechnology; catalog no. sc-162675; clone E-14; lot C0813) and anillin
(1:25; Abcam; catalog no. ab5910; lot GR270489-1). The detection of PRL-
3 using antibodies is known to yield a quite weak signal, and high PRL-3
concentrations are required (Zimmerman et al., 2013). For PRL-3 detection,
antibodies used were from Santa Cruz Biotechnologies (1:200; mouse
antibody; catalog no. sc-130355; clone 318; lot F2111) and Sigma (1:1000;
rabbit antibody; catalog no. P0498; lot 104K4792; and 1:1000; rabbit
antibody; catalog no. SAB2101908; lot QC16627), but we did not observe a
signal in western blot analyses (data not shown). Alexa-fluorophore-
conjugated secondary antibodies (1:1000 for all secondary antibodies;
Invitrogen), Rhodamine-conjugated phalloidin (1:1000; Invitrogen; catalog
no. R415; lot 1090018) and Hoechst 33342 to label nuclei (10 μg/ml) were
also used. Antibody validation details and citations are provided by the
manufacturer. The procedure for the immunofluorescence staining of cysts
has been previously described in detail (Elia and Lippincott-Schwartz,
2009). Briefly, samples were rinsed with phosphate-buffered saline (PBS)
twice and fixed with 4% paraformaldehyde for 30 min. Cells were quenched
with 0.1 M glycine in PBS for 20 min, permeabilized with 0.5% Triton X-
100 in PBS for 10 min and blocked with 10% FBS in PBS with 0.5% Triton
X-100 for 60 min. Samples were then incubated with primary antibodies in
blocking solution at 4°C overnight, followed by washing and incubation
with Alexa-fluorophore-conjugated secondary antibody for 1 h. Images of
the cells were acquired at room temperature (immunofluorescence) on a
spinning disc confocal microscope (PerkinElmer Ultraview ERS) using a
Plan-Apochromat 63×1.4 NA oil objective. Live-cell images were recorded
on the same microscope with a stable monitored temperature of 37°C under
5% CO2, acquiring a single plane every 3 min for a total of 90 min in 3D-
cultured MDCK cells expressing YFP–MKLP-1 pmKATE-PRL-3-WT and
every 5 min for a total of 14 h in 3D-cultured MDCK cells expressing YFP–
MKLP-1 pmKATE-PRL-3-C104S. Images were processed using Imaris
(Oxford Instruments), Volocity (PerkinElmer) or FIJI software (National
Institutes of Health). Contrast or brightness adjustment was applied to the
whole image. In FIJI software, a 50-pixel rolling ball radius was used to
subtract background and a 1-pixel-radius median filter was applied.
Measurement of mitotic spindle angle
Mitotic spindle orientationwasmeasured as described previously (Hao et al.,
2010; Jaffe et al., 2008; Rodriguez-Fraticelli et al., 2010; Wei et al., 2012;
Zheng et al., 2010). Briefly, MDCK cysts were grown and fixed at 72 h,
as described for immunolabeling. Anti-γ-tubulin antibody and Hoechst
33342 (nuclei) were used to stain the mitotic spindle. Confocal images of
metaphase cells in themiddle of the cyst were taken. A line in the direction of
the mitotic spindlewas drawn using ImageJ. Another radial lane between the
center of the cyst and the basal membrane was drawn crossing the first line.
The small angle formed between both lines was measured.
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Measurement of cleavage furrow ingression symmetry
Cleavage furrow positioning during cell division was measured as described
previously (Liu et al., 2012). Briefly, MDCK cysts were grown and fixed at
72 h, as described for immunolabeling. Anti-anillin antibody (cleavage
furrow), Rhodamine–phalloidin (actin) and Hoechst 33342 (nuclei) were
used. Confocal images of cells at cytokinesis were taken when the cleavage
furrow was around 50% ingressed. A line tangent to the apical membrane
and another to the basal membrane were drawn using ImageJ. The distance
between each line and the cleavage furrow was measured to obtain apical
and basal ingression, and the ratio between the basal and apical membrane
ingression was plotted. A value of 1 represents symmetric abscission.
Measurement of abscission timing
Cytokinesis duration was measured in 2D-cultured non-polarized MDCK
cells. mCherry–Aurora-kinase-B was transfected into cells ( jetPRIME,
Polyplus transfection) to stain the cleavage furrow. Pictures were taken
every 10 min during 24 h in an Olympus-ScanRcube5 microscope using a
Plan-Apochromat 20×0.7 NA objective with a stable monitored temperature
of 37°C under 5% CO2. The time between cytokinetic bridge formation and
cleavage was measured.
Immunoblotting
Cells were lysed on ice in HNTG buffer (50 mM Hepes, pH 7.5, 150 mM
NaCl, 10% glycerol, 5 mM EGTA and 1% Triton X-100) containing
complete protease inhibitors (Roche). Equal amounts of lysate protein were
separated by performing SDS-PAGE. Western blotting was performed with
different antibodies against PRL-3 and with secondary anti-mouse or
anti-rabbit antibodies conjugated to horseradish peroxidase (Sigma and
Amersham Biosciences, respectively). Visualization was achieved with the
Western Lightning Plus-ECL solution (Perkin Elmer).
Flow cytometry
To measure the heterogeneous GFP–PRL-3-WT and GFP–PRL-3-C104S
protein levels in MDCK cell lines that stably expressed these constructs,
flow cytometry was performed. A 3×106-cell sample was resuspended in
200 μl of ice-cold PBS. The GFP content of 2×105 cells was measured by
performing flow cytometry (LSR-Fortessa bench top analyzer, BD
Bioscience), and live cells were gated using 1 μg/ml 4′,6-Diamidine-2′-
phenylindole (DAPI) (Roche, catalog no. 10236276001). Cell cycle
analysis was performed as described previously (Schmid and Sakamoto,
2001). Briefly, MDCK cells were resuspended in MEM that lacked Phenol
Red but contained 10% fetal bovine serum (FBS) (both from Gibco, Life
Technologies), 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma),
and 2 mM L-glutamine (Sigma) to a final concentration of 2.6×106 cells/ml.
30 μg/μl of Hoechst 33342 (Sigma) was added to the suspended cell and
incubated at 37°C for 45 min. Finally, DNA content was measured by
performing flow cytometry (LSR-Fortessa bench top analyzer, BD
Bioscience). In order to inhibit Aurora kinase B, MDCK cells were
treated with 2 μM ZM447439 (Santa Cruz Biotechnologies) for 48 h before
being resuspended in PBS.
Ca2+-switch assay
Ca2+-switch experiments were performed as described previously (Chen
and Macara, 2005). Briefly, MDCK cells were plated in 8-well Lab-Tek
II chambers with complete growth medium (normal Ca2+-containing
medium; HCM). After 24 h cells, were switched into low-Ca2+ medium
(LCM). LCM was prepared by supplementing MEM with 2% FBS,
which had been dialysed against 150 mM NaCl overnight. After 16 h of
incubation in LCM, cells were switched back to HCM for the indicated
times.
MS-based phosphoinositide detection
Phosphoinositide quantification was performed as described previously
(Haag et al., 2012). Briefly, MDCK cells were plated in 6-well plates and
grown for 5 days in Matrigel. Cells from two 6-well plates were combined
and subjected to an acidic–neutral extraction of trichloroacetic acid (TCA)-
washed cell pellets using PI(4)P 17:0–20:4 and PI(4,5)P2 17:0–20:4 from
Avanti Polar Lipids as internal standards for quantification. Mass
spectrometry was performed on a QTRAP 5500 instrument (AB Sciex)
equipped with a Triversa NanoMate system (Advion Biosciences).
Phosphoinositides were measured by scanning for neutral losses of m/z
357 (phosphatidylinositol) and m/z 437 (PIP2) on an AB Sciex QTRAP
5500 instrument at collision energies of 25 eVand 35 eV, respectively.Mass
spectra were evaluated using LipidView software (AB Sciex). PIP and PIP2
amounts were normalized to total phospholipids, which was determined in
neutral and acidic phases, as described previously (Özbalci et al., 2013).
MS-based PRL-detection in MDCK cells
Cell lysis, protein digestion and peptide labeling
Three million cells were suspended in lysis buffer (HEPES 200 mM; pH
7.8) containing 1 mg/ml Rapigest SF surfactant (Waters) and a protease
inhibitor cocktail (Sigma, P8340). The cells were pipetted through a pipette
tip 20 times and subsequently heated for 5 min at 95°C, followed by
sonication for 20 min. The proteins were reduced with dithiothreitol, and
cysteine residues were carbamidomethylated with iodoacetamide. The
reduced and carbamidomethylated proteins were digested with lysyl
endopeptidase (Lys-C) (Wako) for 4 h at 37°C followed by a tryptic
(Promega) digestion overnight at 37°C. The resulting peptides were desalted
and dimethyl-labeled on Sep-Pak tC18 1cc 100 mg cartridges (Waters), as
described previously (Boersema et al., 2009). Briefly, the cartridges were
washed with 0.6% acetic acid in 80% acetonitrile and equilibrated with 0.6%
acetic acid. Afterwards, the peptides were loaded onto the cartridges and
washed with 0.6% acetic acid. The three samples were light-, intermediate-
or heavy-dimethyl-labeled with either 4% formaldehyde (CH2O) (Thermo
Fisher Scientific), deuterated formaldehyde (CD2O) (Sigma) or heavy
deuterated formaldehyde (13CH2O) (Isotec) in 50 mM sodium phosphate
buffer (pH 7.5) containing 0.6 M cyanoborohydride (Sigma) or
cyanoborodeuterate (Sigma). The peptides were flushed for 10 min with
labeling solution, followed by washing with 0.6% acetic acid and elution
with 0.6% acetic acid in 80% acetonitrile.
Peptide fractionation by HPLC
Before separation, the dimethyl-labeled samples were mixed in a 1:1:1 ratio
and concentrated in a vacuum centrifuge. The pH of the sample was
increased to above pH 10 with 25% ammonia (Merck), and the volume was
made up to 50 μl with water. The whole sample was separated on an Agilent
1260 infinity high-performance liquid chromatography system equipped
with a Waters XBridge C18 3.5 μm 1×100 mm reversed-phase column at a
flow rate of 75 μl/min with 20 mM ammonium formate at pH 10 and 100%
acetonitrile as buffers. 90 fractions were collected and subsequently
concentrated under vacuum to remove the majority of the organic solvent.
The fractions were desalted and pooled in one step into 18 pooled fractions.
16 of these were pooled by taking one early-, one middle- and one late-
eluting fraction, and two were created by mixing a part of the earliest and
latest fractions together.
Nano-liquid chromatography with tandem mass spectrometry analysis
The 18 fractions were analyzed on a nanoAcquity UPLC system (Waters)
directly connected to an LTQ Orbitrap Velos Pro instrument (Thermo
Scientific) via a Proxeon nanospray source. The peptideswere first trapped on
a nanoAcquity Symmetry C18 5 µm 180 µm×20 mm (Waters) trapping
column and further separated on a nanoAcquity BEH C18 1.7 µm
75 µm×200 mm (Waters) analytical column. The mobile phases were 0.1%
formic acid in water and 0.1% formic acid in acetonitrile (Biosolve). The
applied three-step gradient was 120-min long, ranging from 3% to 40%
acetonitrile. The flow ratewas 300 nl/min. The eluent was directly introduced
into the mass spectrometer through a Pico-Tip emitter 360-µm outer
diameter×20-µm inner diameter, 10-µm tip (New Objective). The capillary
temperature was set to 300°C, and the applied spray voltage was 2.2 kV. The
mass range of the full scanMS spectra was 300–1700 m/z. MS1 spectra were
recorded in profile mode in the Orbitrap. The resolution was set to 30,000.
Lock mass correction was used for internal calibration using a background
ion at m/z 445.12003. The 15 most abundant parent ions were subjected to
fragmentation by using collision-induced dissociation. The normalized
collision energy was set to 40. Charge state screening was enabled with only
multiply-charged ions being selected for fragmentation.
4140
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 4130-4142 doi:10.1242/jcs.190215
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Data analysis
Raw data were processed with proteome discoverer (PD) software version
1.4.0.288 (Thermo Scientific). The MS2 spectra were filtered with a Top N
peaks filter set to 6 with a 100-Da mass window. The resulting data were
searched against the UniProt dog database (26106 sequences) and against
a database comprising the UniProt human database and common
contaminants (86945). The search algorithm applied was Mascot version
2.2 (matrix science). The search parameters were two missed cleavages with
trypsin as enzyme; a mass tolerance of 20 ppm forMS1 and 0.5 Da forMS2.
Carbamidomethylation was chosen as a fixed modification for cysteine
residues, and oxidation on methionine and phosphorylation on serine,
threonine and tyrosine as variable modifications. A false discovery rate of
1% was calculated by the percolator algorithm that is implemented in PD.
Quantification was also performed with PD software with a mass precision
set to 2 ppm. The quantification spectra of all peptides of any PRL isoform
were manually checked.
Statistical analysis
Ordinary two-tailed one- or two-way ANOVA and Tukey’s multiple
comparison tests were performed to study statistical significance: *P≤0.05,
**P≤0.01, ***P≤0.001 and ****P≤0.0001. Statistical analysis was
performed and graphs were generated with Prism (GraphPad).
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R. W., Vasilj, A., Guhr, E., Ibarlucea-Benitez, I., Poser, I. et al. (2013). A
genomic toolkit to investigate kinesin and myosin motor function in cells. Nat. Cell
Biol. 15, 325-334.
Martin-Belmonte, F., Gassama, A., Datta, A., Yu, W., Rescher, U., Gerke, V. and
Mostov, K. (2007). PTEN-mediated apical segregation of phosphoinositides
controls epithelial morphogenesis through Cdc42. Cell 128, 383-397.
Martinez-Garay, I., Rustom, A., Gerdes, H.-H. and Kutsche, K. (2006). The novel
centrosomal associated protein CEP55 is present in the spindle midzone and the
midbody. Genomics 87, 243-253.
Matter, W. F., Estridge, T., Zhang, C., Belagaje, R., Stancato, L., Dixon, J.,
Johnson, B., Bloem, L., Pickard, T., Donaghue, M. et al. (2001). Role of PRL-3,
a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.
Biochem. Biophys. Res. Commun. 283, 1061-1068.
McCaffrey, L. M. and Macara, I. G. (2011). Epithelial organization, cell polarity and
tumorigenesis. Trends Cell Biol. 21, 727-735.
McParland, V., Varsano, G., Li, X., Thornton, J., Baby, J., Aravind, A., Meyer, C.,
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